EUVIMEDEUVIMED entdecken
Open Access

Evaluation of Serum Adipocytokines and Cystatin C As Early Biomarkers in Chronic Kidney Disease Patients and Their Relation to Endothelial Dysfunction

Harish G Bagewadi, Sachin Patil, Manjushree Sugoor, Renuka S Melkundi, Shivalee A, Rohini Kallur, Sangamesh B Tondare

Cureus · 18.05.2026

DOI: 10.7759/cureus.109069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 18.05.2026. Verfasst von Harish G Bagewadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology, Gulbarga Institute of Medical Sciences, Kalaburagi, IND. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is strongly associated with an increased incidence of cardiovascular complications. One of the mechanisms contributing to vascular damage in CKD is the decreased availability of nitric oxide (NO), an important regulator of vascular tone and endothelial function. The adipocytokines have been suggested to play a significant role in the vascular abnormalities observed in patients with impaired renal function.

Methods

This study included 81 patients diagnosed with CKD who were classified into three groups based on their estimated glomerular filtration rate (eGFR). Group I (n=27) consisted of patients with eGFR values ranging from 60-90 ml/min/1.73 m² (CKD stages I-II). Whereas, group II (n=27) included patients with eGFR levels between 15-59 ml/min/1.73 m² (stages III-IV), while group III (n=27) comprised patients with eGFR values below 15 ml/min/1.73 m² (stage V). The serum concentrations of adiponectin, leptin, cystatin C, and endothelial nitric oxide synthase (eNOS) were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits (Elabscience, Houston, Texas, USA).

Results

In the present study, the serum levels of adiponectin, leptin, and cystatin C increased progressively from group I to group III, which was statistically significant (p

Schlagwörter

Stichwörter der Autor:innen

chronic kidney disease (ckd)cystatin cendothelial dysfunctionendothelial nitric oxide synthase (enos)leptin adiponectinnitric oxide synthaseserum adipocytokines

Autor:innen und Institutionen

  • Pharmacology, Gulbarga Institute of Medical Sciences, Kalaburagi, IND.
  • General Medicine, Gulbarga Institute of Medical Sciences, Kalaburagi, IND.
  • Biochemistry, Gulbarga Institute of Medical Sciences, Kalaburagi, IND.
  • Otolaryngology, Gulbarga Institute of Medical Sciences, Kalaburagi, IND.
  • Research, Gulbarga Institute of Medical Sciences, Kalaburagi, IND.
  • General Surgery, Gulbarga Institute of Medical Sciences, Kalaburagi, IND.

Zitieren

APA

Bagewadi, H. G., Patil, S., Sugoor, M., Melkundi, R. S., A, S., Kallur, R., & Tondare, S. B. (2026). Evaluation of Serum Adipocytokines and Cystatin C As Early Biomarkers in Chronic Kidney Disease Patients and Their Relation to Endothelial Dysfunction. Cureus. https://doi.org/10.7759/cureus.109069

Vancouver

Bagewadi HG, Patil S, Sugoor M, Melkundi RS, A S, Kallur R, et al. Evaluation of Serum Adipocytokines and Cystatin C As Early Biomarkers in Chronic Kidney Disease Patients and Their Relation to Endothelial Dysfunction. Cureus. 2026. doi:10.7759/cureus.109069

BibTeX
@article{Bagewadi2026,
  author = {Bagewadi, Harish G and Patil, Sachin and Sugoor, Manjushree and Melkundi, Renuka S and A, Shivalee and Kallur, Rohini and Tondare, Sangamesh B},
  title = {Evaluation of Serum Adipocytokines and Cystatin C As Early Biomarkers in Chronic Kidney Disease Patients and Their Relation to Endothelial Dysfunction},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.109069}
}
Kostenlos starten →